CHMP2B and nasopharyngeal carcinoma: Having established that partial reduction of CHMP2B could protect against and reverse multiple pathophysiologic events in NPC injury cascades in sALS iPSNs (Figs. 2 and 3, Supplemental Figs. 4–10), we next asked whether knockdown of CHMP2B was sufficient to increase neuronal survival.